EE328 Healthcare Costs in Patients With Hepatic Encephalopathy Receiving Rifaximin-α Treatment in the IMPRESS-II Study
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.594
https://www.valueinhealthjournal.com/article/S1098-3015(23)03724-5/fulltext
Title :
EE328 Healthcare Costs in Patients With Hepatic Encephalopathy Receiving Rifaximin-α Treatment in the IMPRESS-II Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03724-5&doi=10.1016/j.jval.2023.09.594
First page :
Section Title :
Open access? :
No
Section Order :
10086